Literature DB >> 29463863

Proposal for a new classification for ocular surface squamous neoplasia.

Rachna Meel1, Rebika Dhiman2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29463863      PMCID： PMC6043581          DOI： 10.1038/s41433-018-0058-7

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  3 in total

1.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.

Authors:  Mahul B Amin; Frederick L Greene; Stephen B Edge; Carolyn C Compton; Jeffrey E Gershenwald; Robert K Brookland; Laura Meyer; Donna M Gress; David R Byrd; David P Winchester
Journal:  CA Cancer J Clin       Date:  2017-01-17       Impact factor: 508.702

2.  Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification.

Authors:  Carol L Shields; Swathi Kaliki; H Jane Kim; Saad Al-Dahmash; Sanket U Shah; Sara E Lally; Jerry A Shields
Journal:  Cornea       Date:  2013-03       Impact factor: 2.651

3.  Clinicodemographic profile and treatment outcome in patients of ocular surface squamous neoplasia.

Authors:  Rachna Meel; Rebika Dhiman; Murugesan Vanathi; Neelam Pushker; Radhika Tandon; Saranya Devi
Journal:  Indian J Ophthalmol       Date:  2017-10       Impact factor: 1.848
  3 in total
  3 in total

1.  Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia.

Authors:  Reza Ghaffari; Sahar Barijani; Arash Alivand; Golshan Latifi; Hamed Ghassemi; Mehran Zarei-Ghanavati; Ali R Djalilian
Journal:  J Curr Ophthalmol       Date:  2021-10-22

Review 2.  Clinical Management of Ocular Surface Squamous Neoplasia: A Review of the Current Evidence.

Authors:  Maria Vittoria Cicinelli; Alessandro Marchese; Francesco Bandello; Giulio Modorati
Journal:  Ophthalmol Ther       Date:  2018-07-20

3.  Ocular surface squamous neoplasia in Northern Thailand: a 16-year review.

Authors:  Napaporn Tananuvat; Muanploy Niparugs; Damrong Wiwatwongwana; Nirush Lertprasertsuk; Pongsak Mahanupap
Journal:  BMC Ophthalmol       Date:  2022-03-12       Impact factor: 2.209
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.